Yahoo Web Search

Search results

    • Gilead's Twice-Yearly Shot Prevents HIV

      Gilead's Twice-Yearly Shot Prevents HIV

      Barrons.com· 2 days ago

      Shares Pop 9%A twice-yearly antiviral injection called lenacapavir prevented HIV in all of the test subjects who had received it in a trial involving...

    • Why Wall Street Is Chasing Ozempic Wannabes

      Why Wall Street Is Chasing Ozempic Wannabes

      The Wall Street Journal· 2 days ago

      HEARD ON THE STREET Gilead Sciences a biotech company focused on treatments for cancer and HIV, isn’t pitching itself as an obesity-drug developer. But...